Investor Materials and Due Diligence

Investor materials can be utilised in both corporate acquisitions and funding rounds as well as in marketing and cooperation negotiations.

A Convincing Pitch Deck

Every company should ensure that their investor materials, incl. investment memorandum and pitch deck, are always in good shape and up-to-date. A good rule of thumb is to always keep your company ready to sell. Above all, this means that the fundamentals of your company are in order and that you have clearly documented them.

Kasve has helped numerous companies in areas such as:

  • Determining funding needs and valuation
  • Compiling an investor memorandum
  • Creating a Pitch Deck

These materials can be utilised in both corporate acquisitions and funding rounds as well as in marketing and cooperation negotiations.

Due Diligence

Carefully prepared Due Diligence improves the chances for success of an investment or corporate acquisition, and reduces the likelihood of a conflict arising. It also enables calculating an optimal value for your company and ensures that you will have the best possible negotiating position.

Kasve’s highly experienced specialists can serve as a partner for an investor or company subject to Due Diligence, assessing the company based on technical aspects, and the quality and comprehensiveness of documentation. This is vital in health technology, as inadequate documentation can delay market entry and produce unexpected costs, resulting in a need for additional financing rounds.

Technical Due Diligence can include:

  • Your organisation, staff and competence
  • Risks and their mitigation
  • Roles and responsibilities
  • Assessment of documentation (technical Due Diligence)
  • IPR assessment
  • Architecture, scalability, used technologies

In addition to Kasve’s specialists, you will have access to our Senior Advisor and Board members as well as our extensive network of experts from a variety of fields.

Let’s write your heroic story!

We’ve helped numerous companies draw up materials for investors.